All treatments
Treatment
Oncaspar 750 U/ml powder for solution for injection/infusion clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
A Randomized Trial of the I-BFM-SG for the Management of Childhood non-mature-B Acute Lymphoblastic Leukemia
This study is looking at new treatments for a type of childhood leukaemia. It aims to see if adding Riximyo to standard chemotherapy helps children live longer without the leukaemia coming back. The study also checks for side effects.
For: Childhood non-mature-B Acute Lymphoblastic LeukemiaGreece · Hungary · Croatia - AuthorisedTherapeutic confirmatory (Phase III)
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
This study looks at new ways to treat children with a type of blood cancer called B-cell acute lymphoblastic leukaemia, which has come back after earlier treatment. It compares different drug combinations to find the most effective and safest options for them.
For: Relapsed Acute Lymphoblastic Leukemia (ALL)Netherlands · Czechia · Italy